Zomagen Biosciences Ltd
Encinitas, CA
Patents
NLRP3-MODULATOREN
EP3999179
N-((1,2,3,5,6,7-HEXAHYDRO-S-INDACEN-4-YL)CARBAMOYL)-4,5,6,7-TETRAHYDROBENZOFURAN-2-SULFONAMID-DERIVATE UND ÄHNLICHE VERBINDUNGEN ALS NLPR3 MODULATOREN ZUR BEHANDLUNG VON MULTIPLER SKLEROSE (MS)
EP3999496
Holder of 2 patents, 1 in force.
From Swissreg, the register of the Federal Institute of Intellectual Property: Swiss patents and European patents with effect in Switzerland. A patent is listed here when its holder’s name is this entity’s.